FindTrial
Sign In

Multicenter Study on the Diagnosis and Prognostic Assessment of Gliomas Based on the STrategically Acquired Gradient Echo (STAGE) in Magnetic Resonance Imaging

Multicenter Study on the Diagnosis and Prognostic Assessment of Brain Gliomas Based on the STrategically Acquired Gradient Echo (STAGE) in Magnetic Resonance Imaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089753
Enrollment
Unknown
Registered
2024-09-14
Start date
2024-09-20
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

Brain glioma group:None
Healthy volunteer group:None

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Suspected glioma patients undergoing surgery in our hospital according to the World Health Organization Classification of central nervous system tumors in 2021; 2.They are between 18 and 80 years old; 3.Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1.There are contraindications for MRI examination, such as metal foreign bodies in the body, women within three months of pregnancy, critically ill patients in need of life support, people with serious mental illness, etc; 2.Previously received craniocerebral surgery or radiotherapy and chemotherapy; 3.Have serious heart, liver, kidney or other serious diseases; 4.MR Data is not available due to artifacts.

Design outcomes

Primary

MeasureTime frame
Strategically Acquired Gradient Echo imaging;Pathological findings;Prognosis;—

Secondary

MeasureTime frame
Initial symptoms;Surgical information;—

Countries

China

Contacts

Public ContactLu Yiping

Huashan Hospital, Fudan University

Susan_LYP@163.com+86 135 2403 5223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026